#Nowhiring Check out our open positions below! ✔️ BD Specialist: lnkd.in/g5qbwpq ✔️ Senior #SystemsBiologist: lnkd.in/g9NpbvC ✔️ Senior #AIScientist: lnkd.in/gKwSb4d

#Standigm recently invited Minkyung Baek (Ph.D. at Washington Univ.), who led the development of RoseTTAFold, to learn about the overview and development process of #RoseTTAFold. Head over to the link below to know about RoseTTAFold: science.sciencemag.org/content/early/…

📺#Standigm was featured in YTN Science a channel that focuses on the fields of science and technology run by the YTN and Ministry of Science and ICT. Full video available here : science.ytn.co.kr/program/progra… #AIdrugdiscovery #drugdiscovery #AI

🦾 Cool and inspiring #Standigm to be highlighted as one of 5 top #AI #startups in #drugdiscovery. “The startup’s solutions eliminate the uncertainty in the drug discovery process to save time and costs during development.” - StartUs Insights 👉Read more: lnkd.in/dVuem8n

Welcome to new BIA members Standigm 🎉 Standigm is a drug discovery company that searches for therapeutic lead compounds using advanced artificial intelligence (AI) methods trained on big biomedical data. Learn more👇 bioindustry.org/member/standig…

Tracxn proudly presents the #SoonicornClub series. Have a look at the "Soonicorn Club 2021: Top Tech Startups In South Korea" covering the country's top tech startups! rebrand.ly/s1n10dz #ai #cloud #decentralized #agriculture #medicine #TechStartups #Soonicorns #Unicorns

🔬 #Standigm signed MOU with Institut Pasteur Korea ("IPK") for #AI based #drugdiscovery research on infectious disease. This MOU will accelerate the discovery of novel #antitubercular drug candidates by conducting RIGHT Fund-awarded projects. 📰Read More: koreaherald.com/view.php?ud=20…

Standigm is listed as "Top 33 Leading #AI #DrugDiscovery Companies in Expertise in Drug Discovery R&D" in the Deep Pharma Intelligence report. Full Report: lnkd.in/gx_VgHpX#Stand… #WorkflowAI #Aidrugdiscovery #Standigm #WorkflowAI #Aidrugdiscovery #ArtificialIntelligence

🔬 Pleased to announce the opening of our new Antibody Research Lab. Standigm’s research capabilities continue to grow. Keep watching for Standigm’s footprints in the AI drug discovery! #Standigm #WorkflowAI #Aidrugdiscovery #artificialintelligence #AI #drugdiscovery #Antibody

🎉 Season's Greetings from all of us from Standigm. Although the world faced many challenges in 2021, we are proud of the year’s scientific advancements and innovation in #AI #drugdiscovery. We look forward to continued success in 2022. Happy New Year, everyone!

Sang Ok Song, Co-founder & COO of Standigm, recently interviewed with Edaily, one of Korea's leading daily economic newspapers. He shared thoughts on the future of the #AI #drugdiscovery industry, and 2022 resolutions of #Standigm. 🎥 Full video: lnkd.in/guRzU-Sx

Do you remember that we have opened the Standigm Synthesis Research Center at the end of last year? Yesterday, the center conducted the first #synthesis experiment, to synthesize derivatives of Standigm’s in-house #AI-driven #cancer #pipeline.

Today, the vice minister of the Ministry of Science and ICT (#MIST) visited the Standigm Seoul office to see how the company's #AI platform works and discuss the future aids from the government to accelerate the AI #drugdiscovery. 📰 Related article: bit.ly/3rH0LSD

🌍#Standigm is going to participate in various #healthcare #events around the world in 1H 2022. Feel free to visit and contact us and explore the future of #AI #drugdiscovery and our other cutting-edge technologies and AI-driven #drug pipelines.

✉️We want to invite YOU to our first official company #newsletter, which will be published on Thursday this week. Don't miss out on all the latest news from Standigm: subscribe to our newsletter! It only takes a few simple clicks: bit.ly/35lcxK3 #AIdrugdiscovery #AI #bio

Standigm will present our recent #AI drug discovery papers at the #MLDD Workshop (#ICLR2022). ✔️ #GRPE: Relative Positional Encoding for Graph Transformer bit.ly/3ES2xp2 ✔️#MetaDTA: Meta-learning-based #drug-target binding affinity prediction bit.ly/3rRKsCo

🏆We’re thrilled to announce that Standigm has been named a finalist in Fast Company’s 2022 World Changing Ideas Awards for our work with Standigm ASK, an #Artificialintelligence #platform for novel #targetidentification. ✔️ Try ASK platform for free: lnkd.in/gH6j7Gf

We recently signed an agreement with Merck Group for AI drug discovery research! 📰Read the full article: lnkd.in/d5vmUgD9 #Standigm #Merck #artificialintelligence #AIdrugdiscovery #AI #drugdiscovery

Join this webinar by Standigm to learn about the proposed meta-learning approach for drug-target binding affinity prediction with the results, limitations and future perspectives. buff.ly/3AzUTOd #ArtificialIntelligence #DrugDiscovery #SmallMolecule